Danaher(DHR)
Focus: Danaher is a $23.9B diagnostics and life sciences conglomerate with 50,000+ employees, operating through a portfolio of diagnostic platforms and biotechnology assets. The company commands significant scale and market position in clinical diagnostics and molecular biology.
Profile data last refreshed 21h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Employees
50000+
Open Jobs
1354+785 this month
Hot — 1656 jobs added in 30d
Net +785 (1656 new, 871 removed). Aggressive expansion phase.
Should You Work at Danaher?
AI assessmentStrong operational platform for commercial, engineering, and manufacturing careers; diagnostics-focused model offers stability but limited upside for pure drug development ambitions.
Why Work Here
- Access to 900+ active job openings across engineering, commercial, and manufacturing—indicating sustained hiring momentum and career mobility within a $23.9B enterprise.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$23.9B
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT06551116QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
N/AHelp build intelligence for Danaher
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.